Current state in the development of candidate therapeutic HPV vaccines
A Yang, J Jeang, K Cheng, T Cheng… - Expert review of …, 2016 - Taylor & Francis
The identification of human papillomavirus (HPV) as an etiological factor for HPV-associated
malignancies creates the opportunity to control these cancers through vaccination …
malignancies creates the opportunity to control these cancers through vaccination …
Perspectives for therapeutic HPV vaccine development
Background Human papillomavirus (HPV) infections and associated diseases remain a
serious burden worldwide. It is now clear that HPV serves as the etiological factor and …
serious burden worldwide. It is now clear that HPV serves as the etiological factor and …
HPV and therapeutic vaccines: where are we in 2010?
The discovery of human papillomavirus (HPV) as a necessary etiological factor for cervical
cancer has spurred the development of preventive and therapeutic HPV vaccines for the …
cancer has spurred the development of preventive and therapeutic HPV vaccines for the …
Therapeutic human papillomavirus vaccines: current clinical trials and future directions
Background: Cervical cancer is the second largest cause of cancer deaths in women
worldwide. It is now evident that persistent infection with high-risk human papillomavirus …
worldwide. It is now evident that persistent infection with high-risk human papillomavirus …
[HTML][HTML] Therapeutic vaccines for high-risk HPV-associated diseases
Cancer is the second leading cause of death worldwide, and it is estimated that Human
papillomavirus (HPV) related cancers account for 5% of all human cancers. Current HPV …
papillomavirus (HPV) related cancers account for 5% of all human cancers. Current HPV …
Emerging human papillomavirus vaccines
ND Christensen - Expert Opinion on Emerging Drugs, 2005 - Taylor & Francis
Human papillomavirus (HPV) infections are a leading cause of virus-associated cancers of
the anogenital, oropharyneal and cutaneous epithelium. The most prevalent of these is …
the anogenital, oropharyneal and cutaneous epithelium. The most prevalent of these is …
Vaccination strategies for the control and treatment of HPV infection and HPV-associated cancer
E Farmer, MA Cheng, CF Hung, TC Wu - Viruses and Human Cancer …, 2021 - Springer
Human papillomavirus (HPV) is the most common sexually transmitted infection, currently
affecting close to 80 million Americans. Importantly, HPV infection is recognized as the …
affecting close to 80 million Americans. Importantly, HPV infection is recognized as the …
The use of both therapeutic and prophylactic vaccines in the therapy of papillomavirus disease
AR Garbuglia, D Lapa, C Sias… - Frontiers in …, 2020 - frontiersin.org
Human papillomavirus (HPV) is the most common sexually transmitted virus. The high-risk
HPV types (ie, HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59) are considered to be the …
HPV types (ie, HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59) are considered to be the …
Prophylactic and therapeutic HPV vaccines: current scenario and perspectives
Y Mo, J Ma, H Zhang, J Shen, J Chen… - Frontiers in cellular …, 2022 - frontiersin.org
Persistent human papillomavirus (HPV) infection is recognized as the main cause of cervical
cancer and other malignant cancers. Although early detection and treatment can be …
cancer and other malignant cancers. Although early detection and treatment can be …
Preventative and therapeutic vaccines for cervical cancer
'High-risk'genotypes of the human papillomavirus (HPV), most commonly HPV genotype 16,
are the primary etiologic agents of cervical cancer. Indeed HPV DNA is detected in 99% of …
are the primary etiologic agents of cervical cancer. Indeed HPV DNA is detected in 99% of …